High materiality7/10
Oscar Health price target raised to $42 from $34 at Raymond James
Why it may matterVerify against the original reporting
Target upgrade suggests continued upside.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Raymond James raises OSCR price target to $42; current price $31.98; upside implied.
- Raymond James raises OSCR PT to $42; price $31.98.
Key facts
- 01
Target: $42
- 02
Posted price: $31.98
- 03
Analyst firm: Raymond James
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.